Open Access Government produces compelling and informative news, publications, eBooks, and academic research articles for the public and private sector looking at health, diseases & conditions, workplace, research & innovation, digital transformation, government policy, environment, agriculture, energy, transport and more.
Home Search
cancer - search results
If you're not happy with the results, please do another search
Cancer Drugs Fund was “politically and intellectually lazy”
The Cancer Drugs Fund, set up to pay for medication not funded by the NHS, was a “huge waste of money” and caused unnecessary suffering for patients
Fighting against breast cancer in Canada
Canadian Cancer Society’s Dr Rob Nuttall and Shawn Chirrey explain how fighting against breast cancer requires ongoing support for research and screening
New developments in breast cancer treatment found
A mechanism used by breast cancer cells to grow and spread has been discovered. This has the potential to open the way for a new generation of treatments
Financing cancer research in Italy
AIRC is involved in financing cancer research in Italy, helping researchers produce quality projects. Professor Federico Caligaris Cappio explains
Targeted drugs: Improving the lives of cancer patients
On Target Laboratories' Dr Sumith A. Kularatne shares his research into targeted drugs and notes the difference this treatment makes to cancer patients
Viruses and cancer: Should we be more afraid?
During the past 30 years it has become exceedingly clear that several viruses play significant roles in the development of various cancers in humans
Tissue-scale factors in predicting cancer treatment outcome
Zhihui Wang and Vittorio Cristini provide evidence that could improve the success of treatment plans and make predicting cancer treatment outcome easier
Current processes for creating cancer treatment plans are primarily based on empirical data from clinical trials, consensus expert panel guidelines, and limited laboratory-based testing. Physicians still face major...
Obesity, liver cancer, metastasis: Future consequences for Europe
Mathias Heikenwälder at the German Cancer Research Center warns of the impact of modern lifestyles and the obesity epidemic on liver cancer and metastasis
Alterations in lifestyles over the last decades, including high caloric diets combined with sedentarism, have increased the worldwide incidence of overweight and metabolic syndrome, characterised by...
Disease-associated myosteatosis in people with cancer: Can it be treated?
Can we prevent the muscle loss associated with some cancers? Dr Vera Mazurak at the University of Alberta is looking into one method of treating myosteatosis
Pathological fat infiltration into muscle is a feature of disease-induced muscle loss that significantly associates with shorter survival in people with cancer. Fat is...
The obesity epidemic and cancer: A disaster in the making?
IARC’s Véronique Terrasse highlights the link between the growing obesity epidemic and cancer in countries around the world, with some alarming statistics
The obesity epidemic is reaching alarming proportions in many countries and has become a major public health concern in both developed and low and middle-income countries (LMICs).
Indeed, the...
Cancer research and training take centre stage in NCI’s work
Open Access Government spoke to the National Cancer Institute’s Dr S Percy Ivy about cancer research and training and the importance of clinical trials
The National Cancer Institute (NCI) is one of 27 institutes that make up the National Institutes of Health (NIH). The NCI is the US federal government’s...
How far have we come on treating gynaecological cancer?
New avenues are opening up for treatment of gynaecological cancer, Professor Gunnar Kristensen of Oslo University Hospital explains to Open Access Government
Surgery remains an important step in the treatment of ovarian cancer. Two earlier randomised studies revealed the same survival rates for patients who had surgery as the first...
Treatments for prostate cancer: Pros and cons
Dr Sumith A Kularatne, vice-president of R&D at On Target Laboratories, explores the pros and cons of various existing treatments for prostate cancer
Prostate cancer (PCa) is the second leading cause of cancer-related deaths in men, with about 1.1 million new cases and approximately 307,000 fatalities per year globally. This...
Regional organisation and the Orkdal model of cancer care
The Orkdal model of cancer care rests on collaboration between specialist oncology and community care in palliative treatment, as Anne Kari Knudsen explains
The Norwegian Orkdal model of cancer care has been called “the future of cancer care”. The aim is to develop and implement a model for optimal cancer...
We are joining the dots on rare forms of cancer, EU health commissioner says
Vytenis Andriukaitis, EU Commissioner for Health and Food Safety, stresses the need for prevention and spotlights joint efforts to tackle rare forms of cancer
The EU vs. cancer battle has been underway for 32 years – more than half of my lifetime. Since the Heads of State of the European...
Diagnostic services for cancer are under growing pressure
Improving cancer survival relies on earlier diagnosis, but diagnostic services are under growing pressure, as Cancer Research UK Policy Manager Sara Bainbridge explains
There are more than 200 different types of cancer, so when someone sees their doctor with possible symptoms, getting the right diagnosis can be complicated. Diagnosing cancer...
Development of integrated non-invasive methods for cancer diagnosis and treatment
Zhihui Wang1, Subrata Sen2, and Vittorio Cristini1
1Center for Precision Biomedicine, Brown Foundation Institute of Molecular Medicine, University of Texas Health Science Center at Houston (UTHealth) McGovern Medical School, Houston, TX 77030, USA
2Department of Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA
Ductal carcinoma in situ...
Drug development for cancer and inflammatory disease
Sumith A Kularatne, Vice President of Research and Development at On Target Laboratories shares the research strides he has made in drug development
Supporting cancer prevention in Europe
AG highlights the European Commission's commitment to cancer prevention in Europe
According to the European Commission, cancer is likely to remain one of the biggest killers of the 21st Century. Overtaking cardiovascular diseases, it now accounts for a quarter of all deaths and remains the largest killer of people between...
AIRC- Italian Association for Cancer Research
AG (November 2016)
"Thankyou Laura, it was a pleasure working with you and I hope we will have future occasions to work together again.
Lucia Ferrero, External Communication
